Drug Shortage Report for 0.9% SODIUM CHLORIDE INJECTION
Report ID | 236464 |
Drug Identification Number | 02395150 |
Brand name | 0.9% SODIUM CHLORIDE INJECTION |
Common or Proper name | 0.9% SODIUM CHLORIDE INJECTION |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 900MG |
Dosage form(s) | SOLUTION SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-09-03 |
Estimated end date | 2024-10-08 |
Actual end date | 2024-10-08 |
Shortage status | Resolved |
Updated date | 2024-10-09 |
Company comments | This product is on backorder. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-10-09 | French | Compare |
v4 | 2024-10-09 | English | Compare |
v3 | 2024-09-04 | English | Compare |
v2 | 2024-09-03 | French | Compare |
v1 | 2024-09-03 | English | Compare |
Showing 1 to 5 of 5